Shanghai Sanyou Medical Co Ltd (688085) - Total Assets
Based on the latest financial reports, Shanghai Sanyou Medical Co Ltd (688085) holds total assets worth CN¥2.34 Billion CNY (≈ $343.00 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Explore Shanghai Sanyou Medical Co Ltd cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
Shanghai Sanyou Medical Co Ltd - Total Assets Trend (2016–2024)
This chart illustrates how Shanghai Sanyou Medical Co Ltd's total assets have evolved over time, based on quarterly financial data. See Shanghai Sanyou Medical Co Ltd shareholders equity for net asset value and shareholders' equity analysis.
Shanghai Sanyou Medical Co Ltd - Asset Composition Analysis
Current Asset Composition (December 2024)
Shanghai Sanyou Medical Co Ltd's total assets of CN¥2.34 Billion consist of 44.8% current assets and 55.2% non-current assets.
| Asset Category | Amount (CNY) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 17.5% |
| Accounts Receivable | CN¥76.97 Million | 3.3% |
| Inventory | CN¥246.11 Million | 10.7% |
| Property, Plant & Equipment | CN¥0.00 | 0.0% |
| Intangible Assets | CN¥88.71 Million | 3.9% |
| Goodwill | CN¥345.87 Million | 15.0% |
Asset Composition Trend (2016–2024)
This chart illustrates how Shanghai Sanyou Medical Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see 688085 company net worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Shanghai Sanyou Medical Co Ltd's current assets represent 44.8% of total assets in 2024, a decrease from 77.7% in 2016.
- Cash Position: Cash and equivalents constituted 17.5% of total assets in 2024, down from 30.5% in 2016.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 17.0% of total assets, an increase from 0.0% in 2016.
- Asset Diversification: The largest asset category is goodwill at 15.0% of total assets.
Shanghai Sanyou Medical Co Ltd Competitors by Total Assets
Key competitors of Shanghai Sanyou Medical Co Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Sinocare Inc
SHE:300298
|
China | CN¥6.25 Billion |
|
T&R Biofab Co. Ltd
KQ:246710
|
Korea | ₩83.86 Billion |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Diagnostic Medical Systems SA
PA:ALDMS
|
France | €62.52 Million |
|
ORTOMA AB B
F:82Y
|
Germany | €161.34 Million |
|
Pulsenmore Ltd. Ordinary Shares
NASDAQ:PLSM
|
USA | $101.85 Million |
|
Allmed Solutions Ltd
TA:ALMD
|
Israel | ILA31.54 Million |
|
Universal Biosensors Inc
AU:UBI
|
Australia | AU$14.94 Million |
Shanghai Sanyou Medical Co Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 5.13 | 4.41 | 11.65 |
| Quick Ratio | 3.81 | 3.27 | 10.90 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | CN¥907.34 Million | CN¥685.17 Million | CN¥1.32 Billion |
Shanghai Sanyou Medical Co Ltd - Advanced Valuation Insights
This section examines the relationship between Shanghai Sanyou Medical Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.58 |
| Latest Market Cap to Assets Ratio | 0.28 |
| Asset Growth Rate (YoY) | 2.0% |
| Total Assets | CN¥2.31 Billion |
| Market Capitalization | $638.74 Million USD |
Valuation Analysis
Below Book Valuation: The market values Shanghai Sanyou Medical Co Ltd's assets below their book value (0.28x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Shanghai Sanyou Medical Co Ltd's assets grew by 2.0% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Shanghai Sanyou Medical Co Ltd (2016–2024)
The table below shows the annual total assets of Shanghai Sanyou Medical Co Ltd from 2016 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.31 Billion ≈ $337.54 Million |
+2.00% |
| 2023-12-31 | CN¥2.26 Billion ≈ $330.93 Million |
+3.20% |
| 2022-12-31 | CN¥2.19 Billion ≈ $320.67 Million |
+9.72% |
| 2021-12-31 | CN¥2.00 Billion ≈ $292.25 Million |
+19.54% |
| 2020-12-31 | CN¥1.67 Billion ≈ $244.47 Million |
+202.95% |
| 2019-12-31 | CN¥551.48 Million ≈ $80.70 Million |
+41.92% |
| 2018-12-31 | CN¥388.58 Million ≈ $56.86 Million |
+15.71% |
| 2017-12-31 | CN¥335.83 Million ≈ $49.14 Million |
+88.91% |
| 2016-12-31 | CN¥177.77 Million ≈ $26.01 Million |
-- |
About Shanghai Sanyou Medical Co Ltd
Shanghai Sanyou Medical Co., Ltd. researches, develops, manufactures, and sells orthopedics implants in China. The company offers spinal and trauma implants under Tytus and Sanyou brand. Its spinal products comprise anterior cervical plate, anterior thoracolumbar, posterior cervical, posterior thoracolumbar, and minimally invasive products; and trauma implants, including shoulder and elbow system… Read more